methionine has been researched along with mefloquine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hatanaka, KC; Hirotani, M; Kano, T; Matsushima, M; Minami, N; Nakamichi, K; Nonaka, T; Saijo, M; Sasaki, H; Sasamori, T; Sato, K; Shiga, T; Shimizu, Y; Shirai, S; Takahashi, I; Tanaka, S; Yabe, I | 1 |
1 review(s) available for methionine and mefloquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for methionine and mefloquine
| Article | Year |
|---|---|
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy.
Topics: Aged; Aged, 80 and over; Antimalarials; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Methionine; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2014 |